Insulin-like growth factor 2: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
Line 77: Line 77:


==References==
==References==
{{reflist}}
{{reflist|2}}


==Further reading==
==Further reading==

Revision as of 18:37, 4 September 2012


Insulin-like growth factor 2 (somatomedin A)
PDB rendering based on 1igl.
Identifiers
Symbols IGF2 ; C11orf43; FLJ22066; FLJ44734; INSIGF; pp9974
External IDs Template:OMIM5 Template:MGI HomoloGene510
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

WikiDoc Resources for Insulin-like growth factor 2

Articles

Most recent articles on Insulin-like growth factor 2

Most cited articles on Insulin-like growth factor 2

Review articles on Insulin-like growth factor 2

Articles on Insulin-like growth factor 2 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Insulin-like growth factor 2

Images of Insulin-like growth factor 2

Photos of Insulin-like growth factor 2

Podcasts & MP3s on Insulin-like growth factor 2

Videos on Insulin-like growth factor 2

Evidence Based Medicine

Cochrane Collaboration on Insulin-like growth factor 2

Bandolier on Insulin-like growth factor 2

TRIP on Insulin-like growth factor 2

Clinical Trials

Ongoing Trials on Insulin-like growth factor 2 at Clinical Trials.gov

Trial results on Insulin-like growth factor 2

Clinical Trials on Insulin-like growth factor 2 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Insulin-like growth factor 2

NICE Guidance on Insulin-like growth factor 2

NHS PRODIGY Guidance

FDA on Insulin-like growth factor 2

CDC on Insulin-like growth factor 2

Books

Books on Insulin-like growth factor 2

News

Insulin-like growth factor 2 in the news

Be alerted to news on Insulin-like growth factor 2

News trends on Insulin-like growth factor 2

Commentary

Blogs on Insulin-like growth factor 2

Definitions

Definitions of Insulin-like growth factor 2

Patient Resources / Community

Patient resources on Insulin-like growth factor 2

Discussion groups on Insulin-like growth factor 2

Patient Handouts on Insulin-like growth factor 2

Directions to Hospitals Treating Insulin-like growth factor 2

Risk calculators and risk factors for Insulin-like growth factor 2

Healthcare Provider Resources

Symptoms of Insulin-like growth factor 2

Causes & Risk Factors for Insulin-like growth factor 2

Diagnostic studies for Insulin-like growth factor 2

Treatment of Insulin-like growth factor 2

Continuing Medical Education (CME)

CME Programs on Insulin-like growth factor 2

International

Insulin-like growth factor 2 en Espanol

Insulin-like growth factor 2 en Francais

Business

Insulin-like growth factor 2 in the Marketplace

Patents on Insulin-like growth factor 2

Experimental / Informatics

List of terms related to Insulin-like growth factor 2

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753



Insulin-like growth factor 2 (IGF-2) is one of three protein hormones that share structural similarity to insulin.

Gene structure

In humans, the IGF2 gene is located on chromosome 11p15.5, a region which contains numerous imprinted genes. In mice this homologous region is found at distal chromosome 7. In both organisms, Igf2 is imprinted, with expression resulting favourably from the paternally inherited allele.

The protein CTCF is involved in repressing expression of the gene, by binding to the H19 imprinting control region (ICR) along with Differentially-methylated Region-1 (DMR1) and Matrix Attachment Region -3 (MAR3). These three DNA sequences bind to CTCF in a way that limits downstream enhancer access to the Igf2 region. The mechanism in which CTCF binds to these regions is currently unknown, but could include either a direct DNA-CTCF interaction or it could possibly be mediated by other proteins

Protein structure

IGF-2 exerts its effects by binding to the IGF-1 receptor. IGF2 may also bind to the IGF-2 receptor (also called the cation-independent mannose 6-phosphate receptor), which acts as a signalling antagonist; that is, to prevent IGF2 responses.

Function

The major role of IGF2 is as a growth promoting hormone during gestation.

Diseases

It is sometimes produced in non-islet cell tumours, causing hypoglycemia (Doege-Potter syndrome).

See also

External links

References

Further reading

  • O'Dell SD, Day IN (1998). "Insulin-like growth factor II (IGF-II)". Int. J. Biochem. Cell Biol. 30 (7): 767–71. PMID 9722981.
  • Butler AA, Yakar S, Gewolb IH; et al. (1999). "Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology". Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 121 (1): 19–26. PMID 9972281.
  • Kalli KR, Conover CA (2004). "The insulin-like growth factor/insulin system in epithelial ovarian cancer". Front. Biosci. 8: d714–22. PMID 12700030.
  • Wood AW, Duan C, Bern HA (2005). "Insulin-like growth factor signaling in fish". Int. Rev. Cytol. 243: 215–85. doi:10.1016/S0074-7696(05)43004-1. PMID 15797461.
  • Fowden AL, Sibley C, Reik W, Constancia M (2006). "Imprinted genes, placental development and fetal growth". Horm. Res. 65 Suppl 3: 50–8. doi:10.1159/000091506. PMID 16612114.

Template:WikiDoc Sources

he:IGF-2